FDA Investigator Vien Q Le
Vien Q Le has conducted inspections on 104 sites in 7 countries as of 23 Jun 2016. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
104
Last Inspection Date:
23 Jun 2016
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America,
Vietnam,
Korea (Republic of),
Belgium,
United Kingdom of Great Britain and Northern Ireland,
Japan,
Saudi Arabia
FDA Investigators that have inspected at least one site in common with Vien Q Le:
Abby Lmozeke Baker,
Alexandra B Pitkin,
Allen F Hall,
Amy Wyan Mai,
Ana Djurdjevic,
Ana S Cabrera,
Anastasia M Shields,
Anderson,
Annette Melendez,
Anthony N Onianwa,
April P Shaw,
Armando Chavez, MS,
Arsen Karapetyan,
Azza Talaat,
Barbara A Burke,
Benjamin S Liao,
Beverly A Thomas,
Bichsa T Tran,
Brant M Schroeder,
Brentley S Collins,
Brian P Putz,
Bryce A May,
Carol B Czerniak,
Cathleen A Carr Sharpe,
Celeta S Coves,
Charles D Boison,
Charles L Larson,
Comyar Shoghi,
Courtney N Long,
Creighton T Tuzon,
Daniel W Cline,
Darla J Christopher,
Darrin E Davis,
Deborah A Greco,
Decarlos A Gomez,
Dell S Moller,
Diana L Ayala,
Diana M Rand,
Diane Cvan Leeuwen,
Don A Leeseberg,
Donna D Gallien, MPH,
Donna Ltartaglino Besone,
Doretha M Tonkins,
Doretha M Wilson,
Durell L Giles,
Dustin R Abaonza,
Dylan R Jock,
Edwin Melendez,
Elizabeth C Ajuzie,
Ellen N Stewart,
Emest F Bizjak,
Emily B Camire,
Emily S Mcgann,
Eric Zhu,
Esther A Ofori,
Gabriel M Guevarra,
Gail L Katz,
Garciam,
Garrad R Poole,
Gene D Arcy,
Geoffrey M Leist,
Gerald Mierle,
Gerald T O'connor,
Grace P Santos,
Greg K Keshishyan,
Helen B Ricalde,
Herminio C Francisco,
Jaclyn N Munsch,
Jacqueline M Bowling,
James C Maclaughlin,
James R Fleckenstein,
Jane C Chen,
Janet Pulver,
Jennifer M Foley,
Jeremy H Nguyen,
Jessica B Clark,
Jinkee Mvila Binayug,
Jinnie Kokiatkulkij,
Jocelyn E Massey,
Joey V Quitania,
John A Iwen,
John L Stevens,
John R Myung,
Joseph J Vannelli,
Joshua S Hoeh,
Juanita Banuelos,
Judy C Nepsa,
Ka L Wong,
Karen J Bak,
Karen L Kosar,
Katherine E Jacobitz,
Kelvin Cheung,
Kelvin X Sanders,
Kenneth S Boehnen,
Lakecha N Lewis,
Laurissa S Flowers,
Laverne Kimble,
Laverne Puckett,
Lawrence H Howell,
Lee Terry Moore,
Leonard H Lavi,
Linda S Mattingly,
Lisa Shin,
Luis A Carrion,
Maira P Brading,
Margarita Santiago,
Mary Ewilkerson Brinsko,
Matthew B Casale,
Matthew J Gretkierewicz,
Maxyne T Lam,
Michael D Garcia,
Michael E Cimaglio,
Michael S Araneta,
Miguel A Martinez Perez,
Minh D Phan,
Mizanne E Lewis,
Mra B Kamberem,
Mra Davism,
Naveen B Walker,
Nianna C Burns,
Nikisha M Bolden,
Nisha C Patel,
Olusegun J Ajayi,
Paul M Chefor,
Phillip L Toy,
Quyen T Tien,
Raymond W Brullo,
Richard J Bashay,
Richard W Tubb,
Robert C Hoover,
Robert S Sweeton,
Rocio Guzman Velazquez,
Roger D Gawne,
Ronnie E Jackson,
Rupa Pradhan,
Sandra A Hughes,
Sandra Sejdinovic,
Santos E Camara,
Scott K Zika,
Selene T Torres,
Shaquenta Y Perkins,
Shelley H Beausoleil,
Sonya L Karsik, RAC,
Steven E Porter, Jr,
Sunitha K Rajaram, PhD,
Susan T Hadman,
Taichun Qin, PhD,
Tania Y Hall,
Tawny L Colling,
Teena H Aiken,
Terrance L Thomas,
Terri L Jones,
Thanh B Tran,
Thanh M Andrews,
Thao T Kwan,
Thao X Tran,
Timothy P Lafave,
Tonia L Sawyer,
Trushani T Desai,
Tuan A Nguyen,
Vanessa R Muller,
Virgilio F Pacio, CSO,
William S Vitale,
Young M Yoon,
Yvette E Guillermo,
Yvette Mlacour Davis,
Yvonne C Wilkes
Vien Q Le's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| February, 2002 | FDA 483 | INLAND EYE & TISSUE BANK - Form 483, 2002-02-01 |
| December, 2000 | EIR | Kingman Hospital Inc - EIR, 2000-12-08 |
| December, 2000 | FDA 483 Response | Kingman Hospital Inc - Form 483R, 2001-02-26 |
| August, 2003 | FDA 483 | General Research Laboratories - Form 483, 2003-08-01 |
| February, 2002 | EIR | Onelegacy-redland - EIR, 2002-02-01 |
| March, 2000 | FDA 483 | AMERICAN RED CROSS BLOOD SERVICES - Form 483, 2000-03-29 |
| May, 2011 | EIR | Sterling Pharma Solutions Limited - EIR, 2011-05-12 |
| August, 2003 | EIR | General Research Laboratories - EIR, 2003-08-15 |
| September, 2000 | EIR | VA GLA Health Care System (WLA) 113 - EIR, 2000-09-08 |
| May, 2000 | EIR | American National Red Cross, The - EIR, 2000-05-16 |
| February, 2002 | FDA 483 Response | Onelegacy-redland - Form 483R, 2002-02-22 |
| December, 2000 | FDA 483 | Kingman Regional Medical Center - Form 483, 2000-12-08 |
| January, 2000 | EIR | San Diego Blood Bank - EIR, 2000-01-31 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more